Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

Kleenex maker Kimberly-Clark will buy Kenvue at a 46% premium, tanking its own stock by 13%. Synergies promise a decent ...

Kimberly-Clark announces the acquisition of Kenvue, the maker of Tylenol, in a landmark $48.7 billion deal to create a ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

One of biggest takeovers so far this year will create a global company with annual revenues of roughly $32 billion.

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health ...

U.S. stocks broadly rose on the first trading day of November, fueled by investor optimism over companies' continued spending spree on artificial intelligence. In the absence of official data due to ...

Kimberly-Clark, maker of Cottonelle and Scott toilet paper, Huggies and Kleenex tissues is buying Kenvue.  The purchase adds ...